His scientific interests lie mostly in Neuroscience, Genetics, Histone, Small molecule and Cell biology. His Neuroscience study integrates concerns from other disciplines, such as Alzheimer's disease, Neurodegeneration and Pharmacology. His work on FMR1, Epigenetics, Exome and Allele as part of his general Genetics study is frequently connected to Multifactorial Inheritance, thereby bridging the divide between different branches of science.
In the subject of general Histone, his work in Histone deacetylase 2 is often linked to Epigenetics of cocaine addiction, thereby combining diverse domains of study. His Small molecule research includes themes of Immunology, Drug repositioning, Zebrafish, Computational biology and Drug discovery. Stephen J. Haggarty combines subjects such as Drug action, Disease, Function and Molecular targets with his study of Computational biology.
Stephen J. Haggarty spends much of his time researching Cell biology, Neuroscience, Histone deacetylase, Epigenetics and Small molecule. The study incorporates disciplines such as Molecular biology and Neurodegeneration in addition to Cell biology. His work deals with themes such as Induced pluripotent stem cell and Drug discovery, which intersect with Neuroscience.
His Histone deacetylase research focuses on subjects like Pharmacology, which are linked to Kinase and In vitro. Stephen J. Haggarty has included themes like Histone and Memory consolidation in his Epigenetics study. His research links Computational biology with Small molecule.
Cell biology, Neuroscience, Neurodegeneration, Induced pluripotent stem cell and Frontotemporal dementia are his primary areas of study. His study in Cell biology is interdisciplinary in nature, drawing from both Histone deacetylase, microRNA, Peptide and Tauopathy. His studies deal with areas such as Psychiatric Disease, Circular RNA, Gene expression and Cereblon as well as Neuroscience.
As a part of the same scientific family, he mostly works in the field of Neurodegeneration, focusing on Activator and, on occasion, Gliosis. Stephen J. Haggarty studied Frontotemporal dementia and Tau protein that intersect with Cell, Drug discovery, Disease mechanisms, Disease etiology and DNA ligase. His Psychological repression study is concerned with the field of Gene as a whole.
His main research concerns Cell biology, Drug discovery, Neural stem cell, Neurodegeneration and Tauopathy. His Cell biology research incorporates themes from Autophagy and Downregulation and upregulation, Gene. His Drug discovery research is multidisciplinary, incorporating elements of Ex vivo, Computational biology and Drug.
His work carried out in the field of Computational biology brings together such families of science as Precision medicine, Stem cell, Disease, Translational science and Cell type. His research integrates issues of Cancer research, Neurite, Corticobasal degeneration, Induced pluripotent stem cell and Neurogenesis in his study of Neural stem cell. His work in Tauopathy covers topics such as Tau protein which are related to areas like Frontotemporal dementia, Cell and Neuroscience.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
Justin Lamb;Emily D. Crawford;David Peck;Joshua W. Modell.
Science (2006)
Small Molecule Inhibitor of Mitotic Spindle Bipolarity Identified in a Phenotype-Based Screen
Thomas U. Mayer;Tarun M. Kapoor;Stephen J. Haggarty;Stephen J. Haggarty;Randall W. King.
Science (1999)
A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles.
Aravind Subramanian;Rajiv Narayan;Steven M. Corsello;Steven M. Corsello;David D. Peck.
Cell (2017)
HDAC2 negatively regulates memory formation and synaptic plasticity
Ji Song Guan;Stephen J. Haggarty;Emanuela Giacometti;Jan Hermen Dannenberg;Jan Hermen Dannenberg.
Nature (2009)
A polygenic burden of rare disruptive mutations in schizophrenia
Shaun M Purcell;Jennifer L Moran;Menachem Fromer;Douglas Ruderfer.
Nature (2014)
Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation
Stephen J. Haggarty;Kathryn M. Koeller;Jason C. Wong;Christina M. Grozinger.
Proceedings of the National Academy of Sciences of the United States of America (2003)
Disrupted in Schizophrenia 1 Regulates Neuronal Progenitor Proliferation via Modulation of GSK3β/β-Catenin Signaling
Yingwei Mao;Xuecai Ge;Xuecai Ge;Xuecai Ge;Christopher L. Frank;Christopher L. Frank;Jon M. Madison.
Cell (2009)
Chemical phylogenetics of histone deacetylases
James E Bradner;Nathan West;Nathan West;Melissa L Grachan;Edward F Greenberg;Edward F Greenberg.
Nature Chemical Biology (2010)
An epigenetic blockade of cognitive functions in the neurodegenerating brain
Johannes Gräff;Damien Rei;Damien Rei;Ji-Song Guan;Ji-Song Guan;Wen-Yuan Wang;Wen-Yuan Wang.
Nature (2012)
Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer's disease.
Mark Kilgore;Courtney A Miller;Daniel M Fass;Daniel M Fass;Krista M Hennig;Krista M Hennig.
Neuropsychopharmacology (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
MIT
Broad Institute
Harvard University
Harvard University
Harvard University
Broad Institute
Harvard University
MIT
Harvard University
Broad Institute
Royal Holloway University of London
William & Mary
German Research Centre for Artificial Intelligence
University of Basel
University of Delaware
South China University of Technology
Forschungszentrum Jülich
Hebrew University of Jerusalem
Keio University
Université du Québec à Rimouski
McMaster University
Florida State University
University of California, Santa Barbara
ETH Zurich
University of British Columbia
Harvard University